← Back to Search

Behavioural Intervention

Stress Management Program for Young Cancer Survivors

N/A
Waitlist Available
Led By Giselle K. Perez, PhD
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post-treatment completion (treatment is approximately 8 weeks)
Awards & highlights

Study Summary

This trialstudies if a program can reduce stress in cancer survivors aged 13-29. It focuses on resilience & stress-management.

Who is the study for?
This trial is for young individuals aged at least 16 who were diagnosed with cancer between ages 14 and 29 and have completed their treatment within the last five years. Participants must be able to speak and read English, willing to use videoconferencing software for sessions, and deemed medically fit by a physician.Check my eligibility
What is being tested?
The study tests a stress management program called Relaxation Response Resiliency Program (3RP-AYA) designed for adolescents and young adults post-cancer treatment. It will assess how feasible and acceptable this program is in helping them manage stress.See study design
What are the potential side effects?
Since this intervention involves a non-medical resiliency training program, there are no direct medical side effects expected from participating in the study.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post-treatment completion (treatment is approximately 8 weeks)
This trial's timeline: 3 weeks for screening, Varies for treatment, and post-treatment completion (treatment is approximately 8 weeks) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
3RP-AYA Acceptability: Five Questions
3RP-AYA Feasibility: Percent of Identified Eligibles Who Enroll
3RP-AYA Feasibility: Proportion of Participants Completing the 3RP-AYA Program

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: 3RP Group SessionsExperimental Treatment1 Intervention
The 3RP-AYA will be delivered in weekly sessions over the course of approximately 8 weeks, for a total of 8 sessions Mini relaxation practice Weekly goal check-ins RR-practice
Group II: Waitlist ControlActive Control1 Intervention
The 3RP-AYA will be delivered in weekly sessions over the course of approximately 8 weeks, for a total of 8 sessions Mini relaxation practice Weekly goal check-ins RR-practice

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
2,929 Previous Clinical Trials
13,198,233 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,658 Previous Clinical Trials
40,924,417 Total Patients Enrolled
Giselle K. Perez, PhDPrincipal InvestigatorMassachusetts General Hospital
1 Previous Clinical Trials
37 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
A Stress Management and Resiliency Program for Adolescent and Young Adult Survivors
Giselle K. Perez Lougee 2019. "A Stress Management and Resiliency Program for Adolescent and Young Adult Survivors". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03768336.
~12 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top